Compare AMR & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMR | BHVN |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2017 | 2022 |
| Metric | AMR | BHVN |
|---|---|---|
| Price | $155.74 | $14.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 17 |
| Target Price | ★ $171.00 | $23.73 |
| AVG Volume (30 Days) | 218.0K | ★ 3.0M |
| Earning Date | 11-06-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,129,481,000.00 | N/A |
| Revenue This Year | $0.49 | N/A |
| Revenue Next Year | $14.90 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $133.64 | $7.75 |
| 52 Week High | $253.82 | $18.24 |
| Indicator | AMR | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 44.77 | 54.30 |
| Support Level | $133.64 | $13.56 |
| Resistance Level | $156.88 | $15.82 |
| Average True Range (ATR) | 9.97 | 1.15 |
| MACD | 0.14 | 0.04 |
| Stochastic Oscillator | 48.31 | 38.49 |
Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.